Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
HK Reddel, LB Bacharier, ED Bateman… - American journal of …, 2022 - atsjournals.org
The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …
updated evidence-based strategy for asthma management and prevention, which can be …
[HTML][HTML] Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
ML Levy, LB Bacharier, E Bateman, LP Boulet… - NPJ primary care …, 2023 - nature.com
Abstract The Global Initiative for Asthma (GINA) was established in 1993 by the World
Health Organization and the US National Heart Lung and Blood Institute to improve asthma …
Health Organization and the US National Heart Lung and Blood Institute to improve asthma …
Managing asthma in adolescents and adults: 2020 asthma guideline update from the National Asthma Education and Prevention Program
MM Cloutier, AE Dixon, JA Krishnan, RF Lemanske Jr… - Jama, 2020 - jamanetwork.com
Importance Asthma is a major public health problem worldwide and is associated with
excess morbidity, mortality, and economic costs associated with lost productivity. The …
excess morbidity, mortality, and economic costs associated with lost productivity. The …
It is time to change the way we manage mild asthma: an update in GINA 2019
Asthma is a heterogeneous lung disease, usually characterised by chronic airway
inflammation. Although evidence-based treatments are available in most countries, asthma …
inflammation. Although evidence-based treatments are available in most countries, asthma …
Managing adult asthma: The 2019 GINA guidelines.
Y Mauer, RM Taliercio - Cleveland Clinic journal of medicine, 2020 - europepmc.org
Asthma is highly prevalent and sometimes deadly, especially in certain groups. The 2019
Global Initiative for Asthma (GINA) guidelines recommend that all asthma patients be treated …
Global Initiative for Asthma (GINA) guidelines recommend that all asthma patients be treated …
[HTML][HTML] Asthma patients' and physicians' perspectives on the burden and management of asthma
KR Chapman, L An, S Bosnic-Anticevich… - Respiratory …, 2021 - Elsevier
Abstract Background The 2021 Global Initiative for Asthma (GINA) report recommends as-
needed inhaled corticosteroid (ICS)/formoterol irrespective of severity, and maintenance and …
needed inhaled corticosteroid (ICS)/formoterol irrespective of severity, and maintenance and …
2021 Canadian Thoracic Society Guideline–a focused update on the management of very mild and mild asthma
CL Yang, EA Hicks, P Mitchell, J Reisman… - Canadian Journal of …, 2021 - Taylor & Francis
Background This asthma guideline update focuses on the management of individuals with
asthma at the mild end of the spectrum. It applies to children 1 year of age and over and …
asthma at the mild end of the spectrum. It applies to children 1 year of age and over and …
2020 NAEPP guidelines update and GINA 2021—asthma care differences, overlap, and challenges
BE Chipps, KR Murphy, J Oppenheimer - The Journal of Allergy and …, 2022 - Elsevier
The 2020 National Asthma Education and Prevention Program Coordinating Committee
Expert Panel Working Group (NAEPP [2020 Focused Asthma Update]) guidelines and the …
Expert Panel Working Group (NAEPP [2020 Focused Asthma Update]) guidelines and the …
Effective asthma management: is it time to let the AIR out of SABA?
A Kaplan, PD Mitchell, AJ Cave, R Gagnon… - Journal of Clinical …, 2020 - mdpi.com
For years, standard asthma treatment has included short acting beta agonists (SABA),
including as monotherapy in patients with mild asthma symptoms. In the Global Initiative for …
including as monotherapy in patients with mild asthma symptoms. In the Global Initiative for …
ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis
Background The Global Initiative for Asthma recommends as-needed inhaled corticosteroid
(ICS)-formoterol as an alternative to maintenance ICS plus short-acting β2-agonist (SABA) …
(ICS)-formoterol as an alternative to maintenance ICS plus short-acting β2-agonist (SABA) …